$BSGM The Company has achieved proof of concept validation through UCLA EP & Animal Labs ongoing from May 2013. BioSig is collaborating with several of the nation's most prestigious cardiac arrhythmia centers to develop, refine and, ultimately, commercialize the PURE EP System, Including: Texas Cardiac Arrhythmia Institute UCLA Cardiac Arrhythmia Center U.H. Case Medical Center in Cleveland William Beaumont Hospital in Michigan Mount Sinai Medical Center in NY Mayo Clinic in Minnesota.